160 related articles for article (PubMed ID: 28708947)
1. Kv10.1 potassium channel: from the brain to the tumors.
Cázares-Ordoñez V; Pardo LA
Biochem Cell Biol; 2017 Oct; 95(5):531-536. PubMed ID: 28708947
[TBL] [Abstract][Full Text] [Related]
2. Kv10.1 K(+) channel: from physiology to cancer.
Ouadid-Ahidouch H; Ahidouch A; Pardo LA
Pflugers Arch; 2016 May; 468(5):751-62. PubMed ID: 26743871
[TBL] [Abstract][Full Text] [Related]
3. De novo KCNH1 mutations in four patients with syndromic developmental delay, hypotonia and seizures.
Fukai R; Saitsu H; Tsurusaki Y; Sakai Y; Haginoya K; Takahashi K; Hubshman MW; Okamoto N; Nakashima M; Tanaka F; Miyake N; Matsumoto N
J Hum Genet; 2016 May; 61(5):381-7. PubMed ID: 26818738
[TBL] [Abstract][Full Text] [Related]
4. KV10.1 K(+)-channel plasma membrane discrete domain partitioning and its functional correlation in neurons.
Jiménez-Garduño AM; Mitkovski M; Alexopoulos IK; Sánchez A; Stühmer W; Pardo LA; Ortega A
Biochim Biophys Acta; 2014 Mar; 1838(3):921-31. PubMed ID: 24269539
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of the K
Barriga-Montoya C; Huanosta-Gutiérrez A; Reyes-Vaca A; Hernández-Cruz A; Picones A; Gómez-Lagunas F
Pflugers Arch; 2018 Mar; 470(3):491-503. PubMed ID: 29218452
[TBL] [Abstract][Full Text] [Related]
6. Alternatively Spliced Isoforms of KV10.1 Potassium Channels Modulate Channel Properties and Can Activate Cyclin-dependent Kinase in Xenopus Oocytes.
Ramos Gomes F; Romaniello V; Sánchez A; Weber C; Narayanan P; Psol M; Pardo LA
J Biol Chem; 2015 Dec; 290(51):30351-65. PubMed ID: 26518875
[TBL] [Abstract][Full Text] [Related]
7. Eag1 K
Han B; Tokay T; Zhang G; Sun P; Hou S
Oxid Med Cell Longev; 2017; 2017():7371010. PubMed ID: 28367272
[No Abstract] [Full Text] [Related]
8. Ether-à-go-go K
Bauer CK; Schwarz JR
J Physiol; 2018 Mar; 596(5):769-783. PubMed ID: 29333676
[TBL] [Abstract][Full Text] [Related]
9. In vivo imaging of tumour xenografts with an antibody targeting the potassium channel K
Napp J; Pardo LA; Hartung F; Tietze LF; Stühmer W; Alves F
Eur Biophys J; 2016 Oct; 45(7):721-733. PubMed ID: 27444284
[TBL] [Abstract][Full Text] [Related]
10. Mutations in the voltage-gated potassium channel gene KCNH1 cause Temple-Baraitser syndrome and epilepsy.
Simons C; Rash LD; Crawford J; Ma L; Cristofori-Armstrong B; Miller D; Ru K; Baillie GJ; Alanay Y; Jacquinet A; Debray FG; Verloes A; Shen J; Yesil G; Guler S; Yuksel A; Cleary JG; Grimmond SM; McGaughran J; King GF; Gabbett MT; Taft RJ
Nat Genet; 2015 Jan; 47(1):73-7. PubMed ID: 25420144
[TBL] [Abstract][Full Text] [Related]
11. Potassium Channel KCNH1 Activating Variants Cause Altered Functional and Morphological Ciliogenesis.
Napoli G; Panzironi N; Traversa A; Catalanotto C; Pace V; Petrizzelli F; Giovannetti A; Lazzari S; Cogoni C; Tartaglia M; Carella M; Mazza T; Pizzuti A; Parisi C; Caputo V
Mol Neurobiol; 2022 Aug; 59(8):4825-4838. PubMed ID: 35639255
[TBL] [Abstract][Full Text] [Related]
12. Procyanidin B1, a novel and specific inhibitor of Kv10.1 channel, suppresses the evolution of hepatoma.
Na W; Ma B; Shi S; Chen Y; Zhang H; Zhan Y; An H
Biochem Pharmacol; 2020 Aug; 178():114089. PubMed ID: 32533968
[TBL] [Abstract][Full Text] [Related]
13. Eag1 Gene and Protein Expression in Human Retinoblastoma Tumors and its Regulation by pRb in HeLa Cells.
Chávez-López MG; Zúñiga-García V; Castro-Magdonel BE; Vera E; Garrido E; Sánchez-Ramos J; Ponce-Castañeda MV; Cabrera-Muñoz ML; Escobar Y; Ortiz CS; Hernández-Gallegos E; Avalos-Fuentes A; Camacho J
Genes (Basel); 2020 Jan; 11(2):. PubMed ID: 31973216
[TBL] [Abstract][Full Text] [Related]
14. Dronedarone blockage of the tumor-related Kv10.1 channel: a comparison with amiodarone.
Meléndez TA; Huanosta-Gutiérrez A; Barriga-Montoya C; González-Andrade M; Gómez-Lagunas F
Pflugers Arch; 2020 Jan; 472(1):75-87. PubMed ID: 31897736
[TBL] [Abstract][Full Text] [Related]
15. External pH modulates EAG superfamily K+ channels through EAG-specific acidic residues in the voltage sensor.
Kazmierczak M; Zhang X; Chen B; Mulkey DK; Shi Y; Wagner PG; Pivaroff-Ward K; Sassic JK; Bayliss DA; Jegla T
J Gen Physiol; 2013 Jun; 141(6):721-35. PubMed ID: 23712551
[TBL] [Abstract][Full Text] [Related]
16. Analysis of the expression of Kv10.1 potassium channel in patients with brain metastases and glioblastoma multiforme: impact on survival.
Martínez R; Stühmer W; Martin S; Schell J; Reichmann A; Rohde V; Pardo L
BMC Cancer; 2015 Nov; 15():839. PubMed ID: 26530050
[TBL] [Abstract][Full Text] [Related]
17. Molecular Dynamics-Derived Pharmacophore Model Explaining the Nonselective Aspect of K
Toplak Ž; Merzel F; Pardo LA; Peterlin Mašič L; Tomašič T
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445705
[TBL] [Abstract][Full Text] [Related]
18. State-independent inhibition of the oncogenic Kv10.1 channel by desethylamiodarone, a comparison with amiodarone.
Gomez-Lagunas F; Barriga-Montoya C; Pardo JP
Pflugers Arch; 2024 Mar; 476(3):323-335. PubMed ID: 38063872
[TBL] [Abstract][Full Text] [Related]
19. Thallium-sensitive fluorescent assay reveals loperamide as a new inhibitor of the potassium channel Kv10.1.
Loza-Huerta A; Milo E; Picones A; Hernández-Cruz A; Luis E
Pharmacol Rep; 2021 Dec; 73(6):1744-1753. PubMed ID: 34213738
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of Eag1 potassium channels in clinical tumours.
Hemmerlein B; Weseloh RM; Mello de Queiroz F; Knötgen H; Sánchez A; Rubio ME; Martin S; Schliephacke T; Jenke M; Heinz-Joachim-Radzun ; Stühmer W; Pardo LA
Mol Cancer; 2006 Oct; 5():41. PubMed ID: 17022810
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
